logo
Suze Orman: 3 Retirement Curveballs To Watch Out For

Suze Orman: 3 Retirement Curveballs To Watch Out For

Yahoo5 hours ago

Most people don't know how long they'll live or what their old age will look like, and there's no shortage of brutal realities. For example, most people will have to reduce or all together stop driving by their mid-70s. Additionally, the lifetime risk of dementia increases to over 50% among those who reach age 75. And most people are likely to develop a condition requiring long-term care in their senior years. You can hope for the best, but you have to prepare for the worst.
Find Out:
Read Next:
In a recent post on her blog, financial expert Suze Orman discussed three common retirement curveballs. Even if you're lucky enough to dodge these curveballs, you need to know what they are and to stress-test your retirement plan to make sure that if you are struck, you — and your finances — can handle it.
This year's Retirement Confidence Survey by the Employee Benefit Research Institute found that 3 in 4 people working expect to go on to continue to earn money in retirement. But that doesn't usually happen.
'In reality, only three in 10 people surveyed who are retired are working for pay,' Orman wrote.
The top reason retirees opt to go back to work is to be able to make money amid rising costs of living. But what if you physically or mentally can't return to a working lifestyle?
Around 46% of Americans ages 75 and older and 24% of those ages 65 to 74 reported having a disability, according to estimates from the Census Bureau's 2021 American Community Survey (ACS). Who's to say that you won't be among the Americans who have a disability in retirement, and one that renders you unable to generate income?
Be Aware:
Maybe you're set on retiring at the full retirement age of 66 or 67, depending on when you were born. Maybe you're thinking you may even push it back a couple years to make some more money before you bid adieu to working life. Consider the cruel possibility that you may not have a choice but to retire early.
'About two-thirds of people surveyed who reported they retired earlier than planned said it wasn't their idea,' Orman wrote, citing data from the Retirement Confidence Survey. 'About 30% said they stopped working due to downsizing or other strategic staffing changes at their job, and another 30% had a health problem or disability that pushed them to retire early. Some people reported stopping work earlier to care for a spouse or another family member.'
Do you want to sail smoothly into retirement? Maybe do leave the full-time hustle and bustle but work as a consultant for a few years before exiting the workforce? Well, yet another brutal reality could strike. A bad health event or some other serious situation in your life may force you to pull the plug fast on the working life.
'Half of the surveyed workers said they plan to have a gradual transition to retirement where they have reduced hours, rather than a cold-turkey full-time stop,' Orman wrote. 'Yet nearly 3 in 4 retirees said they, in fact, didn't have the gradual transition, and instead did an abrupt change from working on Friday and being retired on the following Monday.'
They're called curveballs because we don't see them coming. But that doesn't mean we can't prepare for them so that if they do hit us, we're not taken down with them.
More From GOBankingRates
Clever Ways To Save Money That Actually Work in 2025
This article originally appeared on GOBankingRates.com: Suze Orman: 3 Retirement Curveballs To Watch Out For

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Women usher in strength training's new era
Women usher in strength training's new era

Yahoo

time15 minutes ago

  • Yahoo

Women usher in strength training's new era

Gyms are making space. The future of strength training is female. New flex. Once dominated by men, Crunch Fitness CEO Jim Rowley told Bloomberg that women now account for 50%+ of lifting platform usage. Meanwhile, Planet Fitness is removing more than 40% of cardio machines across 1,700 locations to meet growing demand for weights and functional training, Fitt Insider reports. Validated. Between 2011 and 2021, women's use of free weights increased by 150%, while resistance machine use jumped 558%, per Harrison Co. On Strava, strength training uploads climbed 25% in 2024, making it the fastest-growing sport among women. Longevity lift. More than aesthetics, resistance training is essential for aging well, boosting bone density, preserving muscle, and improving metabolic health. A call to arms, experts like Dr. Stacy Sims and Dr. Gabrielle Lyon are pushing strength as a cornerstone of women's healthspan. Stronger together. Still, 73% of US women—and 83% of women 65+—don't meet CDC strength guidelines, creating a major opportunity for services, coaching, and products tailored to female lifters. Punchline: Strength is the new cardio, and women are leading the charge — transforming gyms, supplements, and the future of healthy aging. This story was produced by Fitt Insider and reviewed and distributed by Stacker.

Ascent Solar Technologies, Inc. Announces Pricing of $2.0 Million Public Offering
Ascent Solar Technologies, Inc. Announces Pricing of $2.0 Million Public Offering

Yahoo

time19 minutes ago

  • Yahoo

Ascent Solar Technologies, Inc. Announces Pricing of $2.0 Million Public Offering

THORNTON, Colo., June 27, 2025 (GLOBE NEWSWIRE) -- Ascent Solar Technologies, Inc. (NASDAQ: ASTI) ('Ascent' or the 'Company'), the leading U.S. innovator in the design and manufacture of featherweight, flexible, and durable CIGS thin-film photovoltaic (PV) solutions, today announced the pricing of a public offering of an aggregate of 1,000,000 shares of its common stock (or pre-funded warrants in lieu thereof) and warrants to purchase up to 1,000,000 shares of common stock (the 'Warrants'), at a combined public offering price of $2.00 per share (or per pre-funded warrants in lieu thereof) and accompanying Warrant. The Warrants will have an exercise price of $2.00 per share, will be exercisable immediately upon issuance, and will expire on the five-year anniversary of the initial issuance date. The closing of the offering is expected to occur on or about June 30, 2025, subject to the satisfaction of customary closing conditions. H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering. The aggregate gross proceeds to the Company from the offering are expected to be $2.0 million before deducting the placement agent's fees and other offering expenses payable by the Company. The Company intends to use the net proceeds from this offering for working capital, product development activities, general and administrative expenses and other general corporate purposes. The securities described above are being offered pursuant to a registration statement on Form S-1 (File No. 333-288300), which was declared effective by the Securities and Exchange Commission (the "SEC") on June 27, 2025. The offering is being made only by means of a prospectus forming part of the effective registration statement relating to the offering. A preliminary prospectus relating to the offering has been filed with the SEC and is available on the SEC's website at and a final prospectus relating to the offering will be filed with the SEC. Electronic copies of the final prospectus, when available, may be obtained on the SEC's website at and may also be obtained, when available, by contacting H.C. Wainwright & Co., LLC at 430 Park Avenue, 3rd Floor, New York, NY 10022, by phone at (212) 856-5711 or e-mail at placements@ This press release shall not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction. About Ascent Solar Technologies, Inc. Backed by 40 years of R&D, 15 years of manufacturing experience, numerous awards, and a comprehensive IP and patent portfolio, Ascent Solar Technologies, Inc. is a leading provider of innovative, high-performance, flexible thin-film solar panels for use in environments where mass, performance, reliability, and resilience matter. Ascent's photovoltaic (PV) modules have been deployed on space missions, multiple airborne vehicles, agrivoltaic installations, in industrial/commercial construction as well as an extensive range of consumer goods, revolutionizing the use cases and environments for solar power. Ascent Solar's research and development center and 5-MW nameplate production facility is in Thornton, Colorado. To learn more, visit Forward-Looking Statements Statements in this press release that are not statements of historical or current fact constitute "forward-looking statements" including statements about the completion of the offering, the satisfaction of customary closing conditions related to the offering and the anticipated use of proceeds therefrom. Such forward-looking statements involve known and unknown risks, uncertainties and other unknown factors that could cause the company's actual operating results to be materially different from any historical results or from any future results expressed or implied by such forward-looking statements, including market and other conditions. We have based these forward-looking statements on our current assumptions, expectations, and projections about future events. In addition to statements that explicitly describe these risks and uncertainties, readers are urged to consider statements that contain terms such as "will," "believes," "belief," "expects," "expect," "intends," "intend," "anticipate," "anticipates," "plans," "plan," to be uncertain and forward-looking. No information in this press release should be construed as any indication whatsoever of our future revenues, stock price, or results of operations. The forward-looking statements contained herein are also subject generally to other risks and uncertainties that are described from time to time in the company's filings with the Securities and Exchange Commission including those discussed under the heading "Risk Factors" in our most recently filed reports on Forms 10-K and 10-Q. Media Contact Spencer Herrmann FischTank PR ascent@

Confessions of a Former Nurx Addict
Confessions of a Former Nurx Addict

Yahoo

time20 minutes ago

  • Yahoo

Confessions of a Former Nurx Addict

It was the beginning of 2019—I had been working at a new company for almost exactly a year, and I was super stressed about my healthcare situation. No, I didn't have any diseases or serious conditions. I wasn't sick or even worried about the possibility of getting sick (although that joke was on me; I caught COVID-19 four separate times in 2020). But for the first time in my life, I found myself in health insurance hell. To be fair, dealing with any healthcare bureaucracy in America is sure to be frustrating and annoying, and will most likely turn into a Kafkaesque nightmare. But when you're 28 and still in the honeymoon phase of a new-ish relationship, an abrupt cut-off of your birth control—with no warning and no clear path to restart it—starts to feel less like a logistical hiccup and more like an existential crisis. More from Flow Space UPDATE: Your State-by-State Guide to Understanding Menopause Insurance Options See, the OB-GYN I saw once a year was on vacation, then booked for the next seven months straight (not that she was in-network anyway), and WITH INSURANCE, the pharmacy was charging me over $130 for one pack, only one month's worth, of pills. The health insurance at my last two jobs had charged me $0 for birth control. In fact, at that point, I had been taking Lo Loestrin FE regularly for 12 years and had never once paid for it. I was, as the kids say, shook. Thankfully, in the midst trying to figure out what to do, I was in the kitchen with a couple of coworkers, when I overheard them mention Nurx. They were both raving about it, but I couldn't tell if it was a fancy boutique or a new dish at their favorite brunch spot—all I could tell was that they both thought Nurx was great. I was having fun making wild guesses in my head, but I also. didn't want to miss out on something seemingly so delightful, so I finally asked them, 'What's Nurx?' In retrospect, it's a little weird that both ladies were surprised I hadn't heard of it. Because, remember this took place pre-COVID and the ensuing telehealth boom. In fact, in 2019, only 10% of Americans ever participated in a telehealth visit, according to a 2024 survey conducted by hims & hers; the most recent data shows a 440% rise in telehealth adoption with 54% having had a telehealth appointment as of early 2025. While I might have been early to to the telemedicine game compared to the general public, I was late to Nurx, which launched in 2015, as far as my work friends were concerned. And they were right. For the next four years, everything about my birth control was seamless. I paid $15 dollars for an initial consult (I believe that fee has gone up to $28 now for birth control patients), and by some incredible stroke of luck, the same afternoon I learned about Nurx, I received a company-wide email explaining that our health insurance plans were changing slightly. The notice didn't go into much detail other than that our copays would be going up—birth control costs definitely weren't mentioned—but I found out via chat with the Nurx team through their app that my medication cost would be $0. They would send me three packs at a time, refills were automatic and shipping was free. Other than the initial $15, I would only have to pay a $3 service fee each month—meaning one full year of Lo Loestrin FE would come out to approximately $51. Just days prior, the same health insurance company wanted me to pay around $87 more for a single pack of medicine from a pharmacy where I'd have to remember to call in all my own refills, go pick them up every single month, wait in a never-ending line and then have some pharmacy tech tell me 'it's gonna be another 30 minutes,' despite the text on my phone announcing 'my prescription is ready for pick-up.' In all honestly, I had become dependent on the impeccable consistency and convenience of Nurx. It felt like the company had truly taken a necessary task (managing your birth control) off your plate and put it on the the most dependable auto-pilot. At the end of 2019, Nurx sent out an email recapping exciting things that had happened that year, and it mentioned how they had not only launched HPV home testing and STI home testing and treatment, but also how August 2019 marked one year of providing PrEP home test kits for HIV prevention. I remember at some point later down the line, the introduced some prescription skin products, but as long as my birth control was being taken care of, I really wasn't paying attention to Nurx. It was great! Then, on March 20, 2023, I received a message from Nurx stating, 'Lo Loestrin Fe will no longer be stocked at our pharmacy. This means we cannot refill your birth control prescription.' But it went on to offer me options, Nurx could send my prescription to a local pharmacy or I could work with their medical team to find something similar to switch to. Considering that I had noticeably (and quickly) gained weight on three different birth controls my OB-GYN had me try before we landed on Lo Loestrin Fe, the decision was a no-brainer. So I asked them to to send to my local pharmacy, and it was OK for the most part. I missed the convenience of getting my prescription shipped directly to my apartment and I could only get one pack at a time instead of three, but I couldn't really complain. At least not until March 21, 2024. The only reason I know some of these exact dates is because I did complain; I complained via a 1,400-word email with certain sections highlighted yellow and other section written with pink or blue or orange. I utilized the 'bold' function more than was necessary. I must imagine that my email was the most colorful 'angry email' Nurx has ever received. What happened? Well, the only thing that Nurx had figured out how to automate yet was the yearly renewal process. Once a year, you had to go onto their platform to manually renew your prescription. I had done exactly that on February 21, 2024 and immediately received a confirmation that my renewal went through; the next day, I got another message confirming that my prescription had been sent to my pharmacy. I was able to pick up my first pack of birth control (of the 12-mont prescription) on March 21, 2024—but when I tried to put in the next month's refill, the pharmacy said they had no record of me or my Lo Loestrin FE in its system. When I reached out to Nurx, I was told they had already sent all remaining refills to my local pharmacy and suggested I speak to them, clearly forgetting that the pharmacy had insisted I get in touch with Nurx. It was a never-ending circle of not getting my birth control, yet continuing to pay a $3 service fee every month. I tried everything I could think of, but Nurx stopped responding to my messages, including my colorful monster-of an email. Despite the unfortunate ending of my time with Nurx, it was, without-a-doubt, it was still the best and easiest approach to birth control prescriptions that I've ever seen. After my March refill ran out and I was just beginning to step into my drama-filled exit with the telehealth platform, the pharmacist who was telling me I didn't exist in their system ended up giving me a free pack of Lo Loestrin FE. My former OB-GYN had moved away, and so I found a new doctor on ZocDoc and went back to relying on my yearly well-woman exam as a means to procure my birth control. I wasn't overly fond of this physician so when I realized she had only prescribed me six months worth of Lo Loestrin Fe, I decided I wasn't even going to bother calling her office to ask for a refill. It was October 2024 at this point, living in a post-COVID world, I expected to find more than one freshly launched telehealth platform that would surely outrival Nurx. After some research I chose to create an account with Pandia Health, a telehealth platform focused solely on women's hormonal care from birth control to hormone replacement therapy (HRT). I knew that Nurx had been adding treatments here and there, but it wasn't until I started looking into new telehealth options that I realized it had evolved into far more than just a birth control platform. They now offer everything from Ozempic and Wegovy for weight management and prescription anti-aging skin care to minoxidil for women's hair loss and essential everyday care for core gynecological issues. But it's their mental health services that seem to have gained the most traction—now standing alongside birth control as one of Nurx's primary offerings. I was surprised to find a number of online reviews comparing Nurx to Brightside Health, a subscription-based online psychiatry and therapy platform that I also happen to use; I started on Brightside in 2020 and remain a member to this day. I only have great things about my experience with Brightside but, for me, comparing the two is an apples-oranges situation. And through writing this piece, it seems somewhat obvious to me that Nurx was going through some massive changes at the time of my issue with them. And considering how disastrous Pandia Health turned out to be—every single month you're expected to fill out and submit a form consenting to your prescription, and since it can take up to 10 days to arrive (if it ever actually does), you're constantly inundated with 'refill reminder' and 'refill consent confirmation reminder' emails—Nurx is still easily the best way I've ever received birth control. When it was working, it was the gold standard. I can only hope that any of the kinks I experienced were from its growth spurt into a fully fledged online clinic for women's health and that the shortcomings I encountered have all been worked out by now. As for me, after Pandia failed to deliver my birth control twice, I stopped using them. I then embarked upon an exhaustive, all-night search for a platform that met, what I thought was, some simple criteria—it needed to either be cheap or take my insurance, carry Lo Loestrin FE, able to send three packs at the same time and actually send them to directly to me through the mail. I finally decided two out of four wasn't that bad. I signed up with an online medical consultation service called Dr.B, which was very simple and very cheap (a consultation is $15, then medication costs are handled by your insurance). But I had to have them send the prescription to a local New York pharmacy and I only get one pack at a time. I thought after such a struggle, I was finally in OK place with my birth control. Do I have to physically drag myself to a pharmacy? Yes, but at least Dr.B doesn't clog up my inbox by sending emails every other day. I actually picked up my first packet of Lo Loestrin Fe placed through Dr.B last Friday. The pharmacist called to let me know it was ready and then said, 'Can you come pick it up ASAP? I told her I'd come in after work. She responded with, 'OK, like you really need to come get it though because we're closing down. Closing down for good.' 'When exactly?' I asked. Her answer? Monday. So that's a new birth control thing to worry about. I'm honestly considering restarting my subscription with Nurx.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store